Thrombosis diagnostic evaluation: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Diagnostic Evaluation==
==Diagnostic Evaluation==
====cDNA-PCR Assays for Gene Mutations and Polymorphisms====
====cDNA-PCR Assays for Gene Mutations and Polymorphisms====
:*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene (PAI-1)  
*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene (PAI-1)  
:*[[Cystathionine beta synthetase]] (CBS) CBS T833C & G919A
*[[Cystathionine beta synthetase]] (CBS) CBS T833C & G919A
:*[[Factor V Leiden]]
*[[Factor V Leiden]]
:*[[Glycoprotein IIIa]] A1/A2 (platelet glycoprotein)
*[[Glycoprotein IIIa]] A1/A2 (platelet glycoprotein)
:*[[Methylenetetrahydrofolate reductase]] (MTHFR) MTHFR C677T
*[[Methylenetetrahydrofolate reductase]] (MTHFR) MTHFR C677T
:*[[Prothrombin]] G20210A
*[[Prothrombin]] G20210A


====Serologic (blood) Tests====
====Serologic (blood) Tests====
:*[[Anticardiolipin antibodies]] (ACLA) IgG and IgM ACLA
*[[Anticardiolipin antibodies]] (ACLA) IgG and IgM ACLA
:*[[Antithrombin III]]
*[[Antithrombin III]]
:*[[Factor VIII]]
*[[Factor VIII]]
:*[[Homocysteine]]
*[[Homocysteine]]
:*[[Lupus anticoagulant]] (LA)
*[[Lupus anticoagulant]] (LA)
:*[[Protein C]]
*[[Protein C]]
:*[[Protein S]]
*[[Protein S]]


====Evaluation of Hypofibrinolysis====
====Evaluation of Hypofibrinolysis====
:*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene ([[PAI-1]])(requires cDNA-PCR assay for gene mutation)
*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene ([[PAI-1]])(requires cDNA-PCR assay for gene mutation)
:*[[Lipoprotein a]] [[Lp(a)]]
*Lipoprotein a (Lp a)


{{Circulatory system pathology}}
{{Circulatory system pathology}}

Revision as of 16:30, 27 February 2013

Thrombosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Classification

Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial
Venous

Differentiating Thrombosis from other Diseases

Arterial
Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications

Prevention

Thrombosis diagnostic evaluation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombosis diagnostic evaluation

CDC onThrombosis diagnostic evaluation

Thrombosis diagnostic evaluation in the news

Blogs on Thrombosis diagnostic evaluation

to Hospitals Treating Thrombosis diagnostic evaluation

Risk calculators and risk factors for Thrombosis diagnostic evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Diagnostic Evaluation

cDNA-PCR Assays for Gene Mutations and Polymorphisms

Serologic (blood) Tests

Evaluation of Hypofibrinolysis

References

Template:WH Template:WS